Biologic adjuvants and bone: current use in orthopedic surgery

Area of Science:

• Orthopedics
• Regenerative Medicine
• Biomaterials Science

Background:

• Normal bone healing restores structure and function after trauma.
• Clinical challenges like nonunion and bone defects necessitate enhanced healing strategies.
• Biologics offer promising solutions for bone repair and regeneration.

Purpose of the Study:

• To review current and emerging biologic strategies for enhancing bone healing.
• To highlight key biologics used in clinical practice and under investigation.
• To discuss the potential of novel biologics in future bone regenerative therapies.

Main Methods:

• Literature review of current biologics for bone healing.
• Analysis of established and investigational biologic agents.
• Summary of clinical applications and future research directions.

Main Results:

• Several biologics are currently used, including bone marrow aspirate concentrate, demineralized bone matrix, platelet-rich plasma, bone morphogenic proteins, and platelet-derived growth factor.
• Emerging biologics such as mesenchymal stem cells, parathyroid hormone, and Nell-like molecule-1 (NELL-1) show future potential.
• The efficacy of novel agents is contingent upon ongoing preclinical and clinical trials.

Conclusions:

• Biologics represent a critical area of research for improving bone healing outcomes.
• A range of biologic options are available and under development for clinical use.
• Continued research is essential to realize the full potential of advanced biologics in bone regeneration.